Keywords: Valeant Pharma, USA, FTC, Divestitures, Ortho Derma, Dermik Labs, Competition, Skin-care products

FTC stipulates divestments for Valeant acquisitions

Article | 14 December 2011

Print This

Canada’s Valeant Pharmaceuticals International (TSX: VRX) has been ordered by the USA’s Federal Trade Commission to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in